The R&D Fund supports small and medium enterprises (SMEs) and scaleups to commercialise products that address the health, social or economic impacts of the COVID-19 pandemic.
It is a $6 million single-round competitive scheme administered by Investment NSW.
The objective of the R&D Fund is to stimulate the development and commercialisation of innovative products that benefit the people of NSW.
The R&D Fund targets products within Technology Readiness Level (TRL) 4-9 to help them move along the TRL scale, enable them to attract large-scale private investment, or expand into global markets.
To be eligible, a business must have:
- An ABN registered in NSW and be based in NSW
- Been operating for at least 12 months
- Ownership that is at least 75 per cent Australian and is not more than 50 per cent owned by another business
- At least $1 million in sales revenue or operating expenditure within the last 12 months or previous financial year
- A product that directly addresses the impact of COVID-19 that it can demonstrate capability and capacity to bring to market within 24 months
- A product that falls within TRL 4-9 on the Technology Readiness Level
- The intellectual property rights to commercialise the product
- Not already received government funding for the same stage of development of the product.
Eligible businesses must provide an operating profit and loss statement for the last 12 months or previous financial year and brief profiles of key personnel.
This Preliminary Application is an early screening document that allows Investment NSW to determine eligibility and the Investment NSW-lead assessment Subcommittee to review the proposal and assess the quality of the application.
Fill
Out